London
11 °C
Manchester
Glasgow
9 °C
Dublin
8 °C
Belfast
Washington
21 °C
Denver
20 °C
Atlanta
28 °C
Dallas
26 °C
Houston Texas
New Orleans
El Paso
Phoenix
33 °C
Los Angeles
-5 °C
27 °C
Featured
Last news
LQR House Launches SWOL Tequila Merch Line, Expanding the Brand’s Bold Identity Beyond the Bottle
MIAMI BEACH, FL / ACCESS Newswire / January 30, 2025 / LQR House Inc. (the "Company" or "LQR House") (NASDAQ:LQR), a niche ecommerce platform specializing in the spirits and beverage industry, is proud to announce the launch of the official merchandise line for its flagship tequila brand, SWOL Tequila. Known for its bold flavors and innovative branding, SWOL Tequila continues to set itself apart with these exciting products designed for tequila enthusiasts who want to carry the SWOL spirit with them everywhere.
CTT Pharma Submits Proposal for NIH Grant
TAMPA, FL / ACCESS Newswire / January 30, 2025 / CTT Pharmaceuticals Holdings, Inc. (OTC:CTTH) has submitted a grant to the National Institutes of Health (NIH) that will aid in further research and commercialization. This grant is being submitted in addition to the Johns Hopkins University grant for clinical trials and this opportunity was suggested to CTT as a grant that would allow for further research and testing.
Spain's top prosecutor denies leaking documents against opposition
Spain's top prosecutor on Wednesday denied leaking legal documents about the partner of the Madrid region's influential conservative leader, legal sources said, a case embarrassing Socialist Prime Minister Pedro Sanchez.
At least 30 dead in India stampede at Hindu mega-festival
A pre-dawn stampede at the world's largest religious gathering killed at least 30 people in India on Wednesday, with many more injured after a surging crowd spilled out of a police cordon and trampled bystanders.
Accidents spotlight fear of training in traffic for professional cyclists
Two shocking accidents this week served as a stark reminder of the dangers faced by professional cyclists on roads they have to share with traffic during training.
At least 15 dead in India stampede at Hindu mega-festival
A pre-dawn stampede at the world's largest religious gathering killed at least 15 people in India Wednesday, with many more injured after a surging crowd spilled out of a police cordon and trampled bystanders.
Crowd chaos and confusion at site of India festival stampede
Journeying across India for the pinnacle celebration of the Hindu calendar, Laxmi and her family were sleeping by the roadside Wednesday as they waited to cleanse themselves in the sacred Ganges river.
Prayer and dance: hundreds of millions in Asia celebrate Year of the Snake
From incense offerings and vibrant lion dances in Beijing to prayer rituals at temples in Bangkok and Taipei, hundreds of millions of people across Asia celebrated the Lunar New Year on Wednesday, ushering in the Year of the Snake.
15 dead in India stampede at Hindu mega-festival
A stampede at the world's largest religious gathering in India killed at least 15 people with many more injured, a doctor at the Kumbh Mela festival told AFP Wednesday.
15 dead in India after stampede at Hindu mega-festival
A stampede at the world's largest religious gathering in India killed at least 15 people with many more injured, a doctor at the Kumbh Mela festival in Prayagraj told AFP Wednesday.
Onco-Innovations' Private Placement Fully Subscribed
Not for distribution to United States wire services or for dissemination in the United States
Jaguar Health Supports Evaluation of FDA-Approved Crofelemer to Address GI Side Effects of GLP-1 and Other Weight Loss Therapies: Files Patent Application with USPTO
Gastrointestinal disorders are the most frequently reported adverse effects during clinical trials of GLP-1 agonists; GI adverse events usually develop in 40-70% of treated patients, and have been reported in up to 85%Crofelemer, approved by the FDA under the brand name Mytesi® for HIV-related diarrhea, has demonstrated a significant benefit in improving gastrointestinal symptoms, including diarrhea, abdominal pain and discomfort, incontinence, bloating and constipation, when studied in populations with HIV-related diarrhea, cancer therapy-related diarrhea, and IBSCrofelemer could have a significant supportive impact on GLP-1 therapies, one of the fastest growing classes of drugs, estimated to be a $56 billion global market in 2025 and projected to grow at a CAGR of 21% to $322 billion 20341
Justera Signs LOI to Acquire Crypto Company Babbage Mining Co.
TORONTO, ON / ACCESS Newswire / January 29, 2025 / Justera Health Ltd. (CSE:VTAL)(OTC PINK:SCRSF) ("Justera" or the "Company") is pleased to announce that it has signed a non-binding LOI to acquire 100% of Babbage Mining Co. ("Babbage Mining"), on January 28, 2025 (the "Transaction").
NanoViricides to Present at the MicroCap Conference on Wednesday, January 29, 2025
SHELTON, CT / ACCESS Newswire / January 29, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it is presenting today, January 29, at 11am at the MicroCap Conference 2025 in Atlantic City, NJ.
'No way out': Grim conditions in El Salvador's mega-prison for gangs
Confined to their cells for all but 30 minutes a day, denied visits, forced to sleep on stainless steel cots without mattresses: this is life in Latin America's biggest prison.
Hundreds of millions in Asia celebrate Year of the Snake
Hundreds of millions of people across Asia celebrate the Lunar New Year with their families on Wednesday, as they bid farewell to the Year of the Dragon and usher in the Year of the Snake.
Helicopter crash that killed Leicester City owner ruled an accident
The helicopter crash that killed the owner of Premier League football club Leicester City was an accident, an inquest jury ruled on Tuesday.
Nepal resumes rescue helicopter flights to Mount Everest
Nepali airlines have resumed rescue helicopter flights to the Everest region, an aviation industry official announced Tuesday, following weeks of suspension prompted by protests from locals citing environmental impact and loss of income from trekkers.
Fast-moving fires torch national parks in southeast Australia
Firefighters were desperately trying to stop a cluster of fast-moving blazes in southeast Australia on Tuesday, as thousands of acres of national park burned and a farming community was forced to evacuate.
The Now Corporation (OTC:NWPN), Utilizing Its Subsidiary Green Rain Solar Inc., Advances EV Infrastructure in Rochester, NY
PASADENA, CA / ACCESS Newswire / January 28, 2025 / The Now Corporation, through its renewable energy subsidiary Green Rain Solar Inc., is making significant progress in enhancing electric vehicle (EV) infrastructure in disadvantaged communities across the United States. The company is pleased to announce that it has completed a utility feasibility study for its flagship project at 1600 West Ridge Road in Rochester, New York, clearing the way to move forward with installation plans.
Retransmission: CTT Pharma and Johns Hopkins University Submits Proposal for $15 Million NIH Grant for Smoking Cessation
TAMPA, FL / ACCESS Newswire / January 28, 2025 / CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) and Johns Hopkins University have successfully submitted our proposal for a NIH Grant that will utilize CTT's patented technology as a smoking cessation product. This grant will allow for clinical trials to be conducted and up to $15 million given to cover these trials. The NIH will begin the review process of this proposal in April 2025 and will notify Johns Hopkins University and CTT Pharma of the results. The CEO of CTT Pharma, Ryan Khouri stated, "This brings us one step closer to helping smokers quit, as 480,000 Americans die every year or 1300 per day from the effects of smoking. The last oral nicotine product that was FDA Approved for smoking cessation was Nicorette gum in 1984. While Nicorette gum has helped many people quit smoking, I believe consumers need more options to quit. CTT's fast acting dissolvable nicotine strips would use substantially less nicotine per dose compared to Nicorette Gum and also dissolve in seconds compared to the gum staying in the mouth for 30 minutes. I also want to price our patented technology at or below the price of Nicorette gum, as pricing of our product should not be a deterrent for a consumer looking to quit smoking. Upon approval from the NIH I'm confident in our teams ability to execute our technology and do not anticipate any problems arising. Johns Hopkins University will be in charge of the clinical trials from start to finish. This past October I attended and briefly spoke at a FDA/NIH hearing about advancing smoking cessation technology. I personally met with many individuals who work for both the FDA and NIH and had productive conversations. Furthermore, I have been asked to appear on Fox Business and Bloomberg for interviews in regards to this grant and have interest in doing both shows. I would prefer to do these interviews once our proposal has been approved but I'm considering doing them beforehand. I firmly believe CTT Pharma's dissolvable nicotine strips are a viable solution to a worldwide problem and should be used as a tool to get people to stop smoking." The World Health Organization states, "The tobacco epidemic is one of the biggest public health threats the world has ever faced, killing over 8 million people a year around the world. More than 7 million of those deaths are results of direct tobacco use while 1.3 million are the result of non-smokers being exposed to second-hand smoke." The CDC says, "Cigarette smoking is the leading cause of preventable death in the United States. Cigarette smoking causes more than 480,000 deaths each year in the United States. This is nearly one in five deaths." CTT will continue to update shareholders as more news becomes available.
Nigerian extradited, charged over sextortion that led to US teen's death
A Nigerian man has been extradited to the United States to face charges in connection with the sextortion of a teenage boy who subsequently committed suicide.
Frenchman goes on trial for murdering ex-partner after years of abuse
A Frenchman is set to stand trial on Wednesday accused of fatally stabbing his former partner, who had complained of enduring years of abuse and repeatedly reported him to the authorities over his harassment.
Tesla, BMW take EU to court over China EV tariffs
Elon Musk's Tesla and German auto giant BMW have challenged EU import tariffs on China-made electric vehicles at the bloc's top court, the European Commission said Monday.
Two Iranian dissidents at 'imminent risk' of execution: activists
Two Iranian men convicted of membership of the People's Mujahedin opposition group, outlawed by the Islamic republic, are at imminent risk of execution after being transferred to a different prison, the organisation and activists said on Monday.
Japan's Fuji TV bosses resign over sex assault scandal
The chairman and president of Japan's Fuji Television resigned Monday, weeks after a celebrity presenter was accused of sexual assault, causing a public relations storm and the mass exit of advertisers.
Japan's Fuji TV bosses resign over sexual assault scandal
The chairman and president of Japan's Fuji Television resigned Monday, weeks after a celebrity presenter and former pop star was accused of sexual assault.
Bird feathers and bloodstains found in Jeju jet engines: report
Bird feathers and bloodstains were found in both engines of the Jeju Air plane that crashed in December, according to a preliminary investigation released Monday.
Bittersweet return for Syrians with killed, missing relatives
Wafa Mustafa had long dreamed of returning to Syria but the absence of her father tarnished her homecoming more than a decade after he disappeared in Bashar al-Assad's jails.
With Trump win, Silicon Valley's right flank takes on Washington
One week into his second administration, Donald Trump has put technology at the forefront, featuring tech billionaires prominently at his inauguration and announcing major AI infrastructure deals from the White House.
Theralase(R) Interim Clinical Data to be Presented at the 2025 AUA Annual Meeting
TORONTO, ON / ACCESS Newswire / January 27, 2025 / Theralase® Technologies Inc. ("Theralase®" or the "Company") (TSXV:TLT)(OTCQB:TLTFF), a clinical stage pharmaceutical company dedicated to the research and development of light, radiation, sound and/or drug-activated small molecules and their formulations, intended for the safe and effective destruction of various cancers, bacteria and viruses is proud to announce that its interim clinical data has been selected for presentation at the American Urological Association ("AUA") Annual Meeting.
The Now Corporation (OTC:NWPN) Through Subsidiary, Green Rain Solar, Partners with KMB Design Group to Advance Urban Solar Projects
PASADENA, CALIFORNIA / ACCESS Newswire / January 27, 2025 / The Now Corporation (OTC:NWPN) is pleased to announce a collaboration between its subsidiary, Green Rain Solar Inc., and KMB Design Group to develop innovative urban solar energy projects. This partnership underscores The Now Corporation's commitment to providing sustainable energy solutions for high-cost urban markets.